Summary
Astellas Pharma US Inc (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a pharmaceutical company that offers injections and tablets. The company offers products such as adenosine injections, regadenoson injection, tacrolimus ointment, tacrolimus extended-release capsules, tacrolimus capsules and injections; amphotericin B liposome for injection, isavuconazonium sulfate, micafungin sodium for injection, erlotinib tablets, enzalutamide capsules, mirabegron extended-release tablets and solifenacin succinate tablets. Its services comprise research and development; patient assistance program and medical safety consulting services. The company’s products are used in therapeutic areas which include cardiology, dermatology, immunology, infectious disease, neuroscience, oncology and urology. Astellas Pharma is headquartered in Northbrook, Illinois, the US.
Astellas Pharma US Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astellas Pharma US Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Astellas Pharma US Enters Into Distribution Agreement With Tecnofarma For Enzalutamide 10
Nagasaki University Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 11
Asset Transactions 12
Cumberland Pharma Acquires Vaprisol From Astellas Pharma 12
Astellas Pharma US Inc - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List of Tables
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Key Facts 1
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astellas Pharma US Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astellas Pharma US Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Astellas Pharma US Enters Into Distribution Agreement With Tecnofarma For Enzalutamide 10
Nagasaki University Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 11
Cumberland Pharma Acquires Vaprisol From Astellas Pharma 12
Astellas Pharma US Inc, Key Competitors 14
Astellas Pharma US Inc, Key Employees 15
List of Figures
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8